Published in Ann Surg on November 01, 1984
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16
Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today (1999) 1.42
Risk factors and management of bile leakage after hepatic resection. World J Surg (2003) 1.40
Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg (2004) 1.27
Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg (1998) 1.20
A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg (1994) 1.19
Usefulness of an estimation of physiologic ability and surgical stress (E-PASS) scoring system to predict the incidence of postoperative complications in gastrointestinal surgery. World J Surg (2005) 0.93
Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg (2002) 0.91
Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg (1990) 0.90
Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. Ann Surg (2001) 0.89
Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection. Int J Colorectal Dis (2009) 0.87
Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol (1992) 0.86
Conditions favoring long-term survival after hepatectomy for hepatocellular carcinomas. Cancer Chemother Pharmacol (1989) 0.85
99mTc-DTPA-galactosyl-human-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory defect: report of a case. Surg Today (2006) 0.83
The importance of prediction model validation and assessment in obesity and nutrition research. Int J Obes (Lond) (2015) 0.83
Results of surgical treatment for multiple (> or =5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg (2004) 0.83
Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. HPB (Oxford) (2014) 0.82
Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. World J Gastroenterol (2012) 0.80
Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg (2005) 0.80
Practical usefulness of ultrasonic surgical aspirator with argon beam coagulation for hepatic parenchymal transection. World J Surg (2005) 0.78
Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg (2004) 0.78
Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer? Langenbecks Arch Surg (2003) 0.78
Simultaneous bile duct and portal venous branch ligation in two-stage hepatectomy. World J Gastroenterol (2011) 0.77
Surgical treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol (1994) 0.77
Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis. World J Gastroenterol (2014) 0.76
Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests. Ann Surg (2016) 0.75
Impaired liver function attenuates liver regeneration and hypertrophy after portal vein embolization. World J Hepatol (2016) 0.75
Safety validation of decision trees for hepatocellular carcinoma. World J Gastroenterol (2015) 0.75
Clinicopathological features of malignancy in hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.75
Liver failure after hepatocellular carcinoma surgery. Langenbecks Arch Surg (2014) 0.75
Safe and permissible limits of hepatectomy in obstructive jaundice patients. World J Surg (2004) 0.75
Liver regeneration following portacaval transposition in dogs. Ann Surg (1953) 3.23
Experience with 150 liver resections. Ann Surg (1983) 3.01
Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery (1984) 1.86
THE INFLUENCE OF AGE UPON THE INCORPORATION OF THYMIDINE-2-C14 INTO THE DNA OF REGENERATING RAT LIVER. Cancer Res (1964) 1.63
Effect of increased hepatic blood flow upon liver regeneration. AMA Arch Surg (1954) 1.50
Estimation of the functional reserve of human liver. Ann Surg (1974) 1.49
Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival. World J Surg (1984) 1.39
Hepatic resection. Pillars of success built on the foundation of 15 years of experience. Am J Surg (1981) 1.26
Recent advances in technique of hepatic lobectomy and results of surgical treatment for primary carcinoma of the liver. Prog Liver Dis (1976) 1.11
Portal systemic shunt for portal hypertension: importance of bromsulphalein retention for prediction of survival. Ann Surg (1972) 0.99
Preoperative estimation of operative risk in liver surgery, with special reference to functional reserve of the remnant liver following major hepatic resection. Jpn J Surg (1979) 0.95
Age changes in structure and responses of reticuloendothelial cells of rat liver. J Reticuloendothel Soc (1967) 0.86
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 8.74
IRF family of transcription factors as regulators of host defense. Annu Rev Immunol (2001) 8.18
Cloning of the gamma chain of the human IL-2 receptor. Science (1992) 4.50
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett (1998) 3.80
Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med (1999) 3.36
Inhibition by kasugamycin of initiation complex formation on 30S ribosomes. Biochem Biophys Res Commun (1971) 3.02
The 2.8 A structure of hydroxylamine oxidoreductase from a nitrifying chemoautotrophic bacterium, Nitrosomonas europaea. Nat Struct Biol (1997) 2.81
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (1995) 2.79
Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett (1998) 2.76
Gallbladder torsion: case report and review of 245 cases reported in the Japanese literature. J Hepatobiliary Pancreat Surg (1999) 2.68
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science (2000) 2.67
Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science (1993) 2.63
The effect of disc degeneration and facet joint osteoarthritis on the segmental flexibility of the lumbar spine. Spine (Phila Pa 1976) (2000) 2.52
Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51
The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol (1996) 2.50
Effect of chronic administration of propranolol on lipoprotein composition. Metabolism (1976) 2.49
Structure of beef liver catalase. J Mol Biol (1981) 2.35
Biochemical and genetic analysis of the effects of amylose-extender mutation in rice endosperm. Plant Physiol (2001) 2.28
Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science (1994) 2.28
Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem (1995) 2.27
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology (2009) 2.23
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science (1993) 2.17
A new computer-assisted method for measuring the tibio-femoral angle in patients with osteoarthritis of the knee. Osteoarthritis Cartilage (2004) 2.11
Kawasaki disease. Relationship with infantile periarteritis nodosa. Arch Pathol Lab Med (1976) 2.10
Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. Biochem Biophys Res Commun (1968) 2.06
Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J Biol Chem (1997) 2.03
Gene induction pathways mediated by distinct IRFs during viral infection. Biochem Biophys Res Commun (2001) 1.97
Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology (1998) 1.97
Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform. Hypertension (1998) 1.96
Three-dimensional structure of a highly thermostable enzyme, 3-isopropylmalate dehydrogenase of Thermus thermophilus at 2.2 A resolution. J Mol Biol (1991) 1.92
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet (1990) 1.88
Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme. J Biol Chem (1987) 1.87
Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery (1984) 1.86
The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci U S A (1998) 1.86
In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity. Antimicrob Agents Chemother (1993) 1.85
Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. Circulation (1997) 1.83
On the mechanism of action of bleomycin: scission of DNA strands in vitro and in vivo. J Antibiot (Tokyo) (1969) 1.80
Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol (2000) 1.73
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
Induction of gene amplification by arsenic. Science (1988) 1.72
Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol (2001) 1.72
Appendiceal mucocele with concomitant colonic cancer. Report of two cases. Dis Colon Rectum (1996) 1.69
Structure of rice ferricytochrome c at 2.0 A resolution. J Mol Biol (1983) 1.67
Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics. J Infect Dis (1994) 1.65
Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 1.64
Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med (2000) 1.63
New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: in vitro and in vivo studies. J Am Coll Cardiol (1995) 1.62
Amino acid sequence of copper,zinc-superoxide dismutase from spinach leaves. J Biochem (1986) 1.62
Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer (1990) 1.61
Allelotype study of primary hepatocellular carcinoma. Cancer Res (1991) 1.61
Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol (1998) 1.61
The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol (1996) 1.60
Mitochondrial morphological and functional defects in yeast caused by yme1 are suppressed by mutation of a 26S protease subunit homologue. Mol Biol Cell (1994) 1.57
Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol (2001) 1.54
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
Transcatheter arterial embolization of ruptured pseudoaneurysms with coils and n-butyl cyanoacrylate. J Vasc Interv Radiol (2000) 1.54
Development and validation of an ultrasonographic activity index of Crohn's disease. Eur J Gastroenterol Hepatol (1999) 1.51
Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn (1991) 1.51
Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest (1998) 1.51
Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology (1997) 1.50
Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res (1999) 1.48
Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology (1993) 1.48
Is taurine effective for treatment of painful muscle cramps in liver cirrhosis? Am J Gastroenterol (1993) 1.47
Myocardial velocity gradient as a new indicator of regional left ventricular contraction: detection by a two-dimensional tissue Doppler imaging technique. J Am Coll Cardiol (1995) 1.46
Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation (1995) 1.46
Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene (1997) 1.46
Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa. Appl Microbiol (1968) 1.43
Evaluation of cardiac sympathetic nervous function by 123I-metaiodobenzylguanidine scintigraphy in insulin-treated non-insulin dependent diabetics with hypoglycemia unawareness. Intern Med (1996) 1.43
Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis. J Neurol Sci (1993) 1.42
Autofluorescence in indomethacin-induced gastric mucosal lesions in rats. J Gastroenterol (2000) 1.42
Oral and maxillofacial tumours in children: a review. Br J Oral Maxillofac Surg (1997) 1.41
Steroid-refractory severe ulcerative colitis responding to cyclosporine and long-term follow-up. J Gastroenterol (1998) 1.40
Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology (1997) 1.40
The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie (1999) 1.40
Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival. World J Surg (1984) 1.39
Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J Gastroenterol Hepatol (2000) 1.39
Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens. Acta Cytol (1995) 1.39
Generalized peritonitis due to spontaneously perforated pyometra presenting as pneumoperitoneum: report of a case. Surg Today (2000) 1.39
Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT. J Exp Med (1999) 1.39
Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog (1997) 1.38
Phosphorylation and inactivation of kanamycin by Pseudomonas aeruginosa. J Antibiot (Tokyo) (1968) 1.38
Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells (2001) 1.38
Primary dual defect of cholesterol and bile acid metabolism in liver of patients with intrahepatic calculi. Gastroenterology (1995) 1.38
The common gamma-chain for multiple cytokine receptors. Adv Immunol (1995) 1.38
Regional cerebral blood flow in pediatric moyamoya disease: age-dependent decline in specific regions. Childs Nerv Syst (1998) 1.38
Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol (1999) 1.36
Activation of the transcription factor ISGF3 by interferon-gamma. Biol Chem (1999) 1.35
Inactivation and phosphorylation of kanamycin by drug-resistant Staphylococcus aureus. Appl Microbiol (1968) 1.35
Estrogen and progesterone receptors in gastric cancer. Cancer (1986) 1.35
A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol (1996) 1.35
Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem (2000) 1.34